Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience

M Navratil; Z Koristek; F Folber

首页> 外文期刊>Critical care : >Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience

【24h】

Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience

机译：同种异体造血干细胞移植后，在接受去纤蛋白多核苷酸治疗静脉阻塞性疾病的患者中，CRRT-CVVH在血液肿瘤ICU中的应用

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Critical care :》 |2010年第1期|共页
作者
M Navratil; Z Koristek; F Folber;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT) [J] . Paul G. Richardson, Angela R. Smith, Nancy A. Kernan, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
2. Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT) [J] . Paul G. Richardson, Angela R. Smith, Nancy A. Kernan, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：对白痴治疗肝静脉闭塞疾病/正弦梗阻综合征（VOD / SOS）和呼吸机或透析依赖性血管生成干细胞移植（HSCT）的肝脏静脉闭塞症/正弦梗阻综合征（VOD / SOS）和透析依赖性的汇总分析
3. DEFIBROTIDE FOR THE TREATMENT OF SEVERE HEPATIC VENO-OCCLUSIVE DISEASE: A SUBGROUP ANALYSIS OF CLINICAL BENEFIT FOR PEDIATRIC PATIENTS AS DETERMINED BY NUMBER NEEDED TO TREAT (NNT) TO ACHIEVE COMPLETE RESPONSE AND TO IMPROVE SURVIVAL AT DAY 100 POST HEMATOPOIETIC STEM CELL TRANSPLANT [J] . Grupp Stephan A., Richardson Paul G., Kernan Nancy A., Pediatric blood & cancer . 2015,第Suppla2期

机译：去氟肽治疗严重的肝静脉阻塞性疾病：根据需要治疗的患者（NNT）的数量确定小儿患者临床获益的亚组分析，以达到完全缓解并在术后100天改善存活率
4. A Bayesian Review of the Meta-Analysis on the Efficacy of Bone Marrow-Derived Cells Transplantation in Adult Patients with Heart Diseases [C] . Siew-Pang Chan, Rosalind Lee, Kim-Leng Poh World Congress on Engineering . 2009

机译：贝叶斯审查骨髓源细胞移植在成人患者心脏病患者中的疗效综述
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience [O] . M Navratil, Z Koristek, F Folber 2010

机译：同种异体造血干细胞移植后在接受去纤颤肽治疗静脉闭塞性疾病的患者中CRRT-CVVH在血液肿瘤ICU中的应用
7. Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience [O] . Navratil, M, Koristek, Z, Folber, F 2010

机译：同种异体造血干细胞移植后，在接受去纤维蛋白多核苷酸治疗静脉阻塞性疾病的患者中，CRRT-CVVH在血液肿瘤ICU中的应用

Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience

著录项

引文网络

相似文献

相关主题

期刊订阅